George Sledge
Chief Medical Officer · Stanford Health Care
Credentials: · · · · ·
History
- Present
Division of Oncology · Stanford Health Care
- Present
- Present
1981–1983
1977–1980- 1973–1977
Research
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
New England Journal of Medicine · 2018 · Last of 30 authors · 1,827 citations
Journal of Clinical Oncology · 2017 · First of 18 authors · 1,358 citations
The Lancet Oncology · 2010 · 1,100 citations
85 papers
49 papers
34 papers
- EP
30 papers
28 papers
27 papers
- MO
21 papers
- SM
19 papers
Grants
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $19.5K · Indiana University Indianapolis
- 1985–1988
Biology of Steroid-Receptor-Negative Breast Cancer
National Cancer Institute · R23
Contact PI · $140.3K · Indiana University Indianapolis
Clinical trials
- 2017–2022
Principal investigator · Completed · Phase 1
George W. Sledge Jr.
- 2008–2010
- 2007–2009
Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
Principal investigator · Terminated
Hoosier Cancer Research Network
- 2006–2009
Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer
Principal investigator · Completed
Indiana University